We independently review everything we recommend. When you buy through our links, we may earn a commission. Learn more› By Max Eddy Max Eddy is a writer who has covered privacy and security — including ...

We wouldn't blame you for assuming that AI, being a computer, would be better at generating passwords than a human. After all, people use AI to do everything from writing their emails to generating a ...

Sure, calculating bits of entropy is a way to determine password strength for a single password, but Gemini generated five passwords in a row with the exact same character-type sequence. The AI did ...

Generate:Biomedicines is the latest biotech to benefit from a renewed appetite from investors for publicly listed drug developers. Generate—which will list its stock on the Nasdaq this morning under ...

Jon Gilbert is a Features Writer for Android Police. I've covered Android since 2021, focusing on writing features and guides about Android apps and features that directly affect users. I've attended ...

Security experts warn against using AI-generated passwords after finding predictable patterns in outputs from ChatGPT, Gemini, and Claude that make them vulnerable to attacks. PCWorld reports that AI ...

One of the most persistent and underestimated cybersecurity risks is near-identical password reuse. This is the practice of adding or changing a character in an existing password, instead of creating ...

Jake Peterson is Lifehacker’s Tech Editor, and has been covering tech news and how-tos for nearly a decade. His team covers all things technology, including AI, smartphones, computers, game consoles, ...

The era of AI has not been particularly great for cybersecurity. We know that vibe-coded websites and apps have been a hotbed of security flaws that leave the platforms vulnerable to attacks. It turns ...

Creating strong passwords means balancing security with memorability, so your accounts stay safe without needing a sticky note on your monitor. Password security tips now favor passphrases—long ...

Clinical-stage antibody company Generate:Biomedicines is the latest biotech to mull going public as momentum for IPOs continues to build. The Flagship-founded biotech has yet to set out how many ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Generate:Biomedicines raised ...